This inventor holds 5 USPTO granted patents. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 1995-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1999
Title: The Innovations of Robert S. Andrews
Introduction
Robert S. Andrews is a notable inventor based in San Juan Capistrano, California. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that can modulate RNA activity. With a total of 5 patents to his name, Andrews has established himself as a key figure in the realm of antisense agents.
Latest Patents
One of his latest patents focuses on the synthesis of 3-deazapurines. This invention relates to compounds based on the 3-deazapurines ring system and methods for making such compounds. The invention is particularly relevant to the field of 'antisense' agents, which are capable of specific hybridization with nucleotide sequences of RNA. The 3-deazapurine-containing compounds can be useful for modulating RNA activity when incorporated into oligonucleotides. These oligonucleotides and their analogs serve various therapeutic and diagnostic purposes, including treating diseases, regulating gene expression, and diagnosing conditions through antisense interactions with RNA.
Career Highlights
Robert S. Andrews is currently associated with Isis Pharmaceuticals, Inc., where he continues to innovate in the field of biochemistry. His work has implications for a wide range of applications, from therapeutic treatments to diagnostic tools.
Collaborations
Andrews has collaborated with notable colleagues, including Oscar L. Acevedo and P. Dan Cook, contributing to the advancement of research in his field.
Conclusion
Robert S. Andrews is a distinguished inventor whose work in the synthesis of 3-deazapurines has the potential to impact therapeutic and diagnostic practices significantly. His contributions to the field of biochemistry continue to pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
